These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

168 related items for PubMed ID: 9156723

  • 1. Impact of treatment on bronchial hyperresponsiveness.
    de Jongste JC.
    Pediatr Allergy Immunol; 1996; 7(9 Suppl):18-24. PubMed ID: 9156723
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Preventive therapy of asthma steroid and other antiasthmatic drugs.
    Nagy L.
    Acta Microbiol Immunol Hung; 1998; 45(1):131-4. PubMed ID: 9595163
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Cromolyn sodium or nedocromil in childhood asthma: does it matter?
    König P, Grigg CF.
    Clin Exp Allergy; 2000 Feb; 30(2):164-71. PubMed ID: 10651767
    [No Abstract] [Full Text] [Related]

  • 6. Long-term treatment with sodium cromoglycate, nedocromil sodium and beclomethasone dipropionate reduces bronchial hyperresponsiveness in asthmatic subjects.
    Orefice U, Struzzo P, Dorigo R, Peratoner A.
    Respiration; 1992 Feb; 59(2):97-101. PubMed ID: 1320287
    [Abstract] [Full Text] [Related]

  • 7. [Current concepts on the treatment of bronchial asthma].
    Stelmach R, Cukier A, Vargas FS.
    Arq Bras Cardiol; 1995 Nov; 65(5):439-43. PubMed ID: 8729864
    [No Abstract] [Full Text] [Related]

  • 8. [The treatment of early asthma].
    Haahtela T.
    Nord Med; 1992 Nov; 107(4):104-7. PubMed ID: 1561067
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Drug treatment of airway inflammation in asthma.
    Blake KV.
    Pharmacotherapy; 2001 Mar; 21(3 Pt 2):3S-20S. PubMed ID: 11253868
    [Abstract] [Full Text] [Related]

  • 12. [Drug treatment of bronchial asthma in children].
    Korsgaard B.
    Ugeskr Laeger; 1977 Aug 01; 139(31):1869-71. PubMed ID: 410132
    [No Abstract] [Full Text] [Related]

  • 13. [Poor compliance: what are the sequelae for the asthmatic patient?].
    Salmeron S.
    Rev Pneumol Clin; 2005 Jun 01; 61 Spec No 1():5-9. PubMed ID: 16208247
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Pharmaceutical treatment strategies for childhood asthma.
    Carlsen KH, Carlsen KC.
    Curr Opin Allergy Clin Immunol; 2008 Apr 01; 8(2):168-76. PubMed ID: 18317028
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Prolonged protection of the new inhaled corticosteroid fluticasone furoate against AMP hyperresponsiveness in patients with asthma.
    van den Berge M, Luijk B, Bareille P, Dallow N, Postma DS, Lammers JW.
    Allergy; 2010 Dec 01; 65(12):1531-5. PubMed ID: 20560909
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.